Jiangsu Hengrui Medicine Co Ltd Financial Flexibility Index
Jiangsu Hengrui Medicine Co Ltd financial flexibility index. Jiangsu Hengrui Medicine Co Ltd (600276) has a Financial Flexibility Index of 0.63x as of September 2025. Free cash flow of CN¥5.26 Billion (operating CF CN¥4.81 Billion minus capex CN¥446.90 Million) represents 1% of total liabilities (CN¥8.30 Billion). Explore 600276 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Jiangsu Hengrui Medicine Co Ltd (1999–2024)
Financial flexibility index of Jiangsu Hengrui Medicine Co Ltd from 1999 to 2024. Historical Financial Flexibility Index trend for Jiangsu Hengrui Medicine Co Ltd across 26 annual periods. Check Jiangsu Hengrui Medicine Co Ltd (600276) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Jiangsu Hengrui Medicine Co Ltd Financial Flexibility Index by Year (1999–2024)
Jiangsu Hengrui Medicine Co Ltd financial flexibility index by year from 1999 to 2024. Year-by-year free cash flow to debt coverage for Jiangsu Hengrui Medicine Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Jiangsu Hengrui Medicine Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.32x | CN¥9.39 Billion | CN¥7.42 Billion | CN¥4.05 Billion | ▼ -30.0% |
| 2023 | 3.32x | CN¥9.13 Billion | CN¥7.64 Billion | CN¥2.75 Billion | ▲ +301.4% |
| 2022 | 0.83x | CN¥3.26 Billion | CN¥1.27 Billion | CN¥3.94 Billion | ▼ -48.1% |
| 2021 | 1.59x | CN¥5.88 Billion | CN¥4.22 Billion | CN¥3.69 Billion | ▲ +57.5% |
| 2020 | 1.01x | CN¥3.99 Billion | CN¥3.43 Billion | CN¥3.94 Billion | ▼ -39.5% |
| 2019 | 1.67x | CN¥4.38 Billion | CN¥3.82 Billion | CN¥2.62 Billion | ▲ +29.7% |
| 2018 | 1.29x | CN¥3.30 Billion | CN¥2.77 Billion | CN¥2.56 Billion | ▼ -7.7% |
| 2017 | 1.40x | CN¥2.93 Billion | CN¥2.55 Billion | CN¥2.10 Billion | ▼ -45.1% |
| 2016 | 2.54x | CN¥3.70 Billion | CN¥2.59 Billion | CN¥1.46 Billion | ▲ +8.5% |
| 2015 | 2.35x | CN¥2.67 Billion | CN¥2.28 Billion | CN¥1.14 Billion | ▼ -0.2% |
| 2014 | 2.35x | CN¥1.87 Billion | CN¥1.57 Billion | CN¥796.98 Million | ▼ -27.1% |
| 2013 | 3.22x | CN¥1.82 Billion | CN¥1.36 Billion | CN¥564.40 Million | ▲ +1.7% |
| 2012 | 3.17x | CN¥1.43 Billion | CN¥958.37 Million | CN¥450.01 Million | ▲ +30.4% |
| 2011 | 2.43x | CN¥1.07 Billion | CN¥527.36 Million | CN¥439.47 Million | ▲ +52.0% |
| 2010 | 1.60x | CN¥672.68 Million | CN¥385.95 Million | CN¥420.80 Million | ▼ -8.1% |
| 2009 | 1.74x | CN¥580.77 Million | CN¥439.12 Million | CN¥333.85 Million | ▲ +74.9% |
| 2008 | 0.99x | CN¥228.67 Million | CN¥117.46 Million | CN¥229.91 Million | ▲ +32.5% |
| 2007 | 0.75x | CN¥285.72 Million | CN¥218.87 Million | CN¥380.51 Million | ▼ -57.2% |
| 2006 | 1.75x | CN¥352.47 Million | CN¥266.18 Million | CN¥201.07 Million | ▲ +6.7% |
| 2005 | 1.64x | CN¥290.94 Million | CN¥227.88 Million | CN¥177.10 Million | ▲ +46.5% |
| 2004 | 1.12x | CN¥288.52 Million | CN¥209.41 Million | CN¥257.33 Million | ▲ +73.6% |
| 2003 | 0.65x | CN¥353.44 Million | CN¥136.82 Million | CN¥547.34 Million | ▲ +47.5% |
| 2002 | 0.44x | CN¥172.74 Million | CN¥49.84 Million | CN¥394.60 Million | ▼ -44.9% |
| 2001 | 0.80x | CN¥287.07 Million | CN¥11.49 Million | CN¥361.03 Million | ▲ +147.1% |
| 2000 | 0.32x | CN¥100.95 Million | CN¥19.61 Million | CN¥313.71 Million | ▲ +78.8% |
| 1999 | 0.18x | CN¥54.21 Million | CN¥33.89 Million | CN¥301.17 Million | — |